Abbott Laboratories (ABT) Other Non-Current Assets (2009 - 2020)

Abbott Laboratories has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $824.0 million for Q4 2020.

• Other Non-Current Assets for Q4 2020 came in at $824.0 million, up 19.94% year-over-year; the trailing twelve-month figure through Dec 2020 was $824.0 million (up 19.94% YoY), and the FY2020 annual result was $824.0 million, up 19.94% from the prior year.
• Other Non-Current Assets came in at $824.0 million for Q4 2020 at Abbott Laboratories, up from $687.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.8 billion in Q4 2016 to a low of $2.0 million in Q1 2016.
• The 5-year median for Other Non-Current Assets is $148.5 million (2017), against an average of $647.2 million.
• Across the five-year window, Other Non-Current Assets jumped 2521.9% in 2016 and sank 97.74% in 2017, its largest moves.
• Abbott Laboratories' Other Non-Current Assets stood at $2.8 billion in 2016, then tumbled by 93.61% to $176.0 million in 2017, then soared by 231.25% to $583.0 million in 2018, then gained by 17.84% to $687.0 million in 2019, then advanced by 19.94% to $824.0 million in 2020.
• The last three Other Non-Current Assets figures came in at $824.0 million (Q4 2020), $687.0 million (Q4 2019), and $583.0 million (Q4 2018), per Business Quant data.